MarketScreener Editorial Features Biosante Pharmaceuticals Inc Nasdaq
Equities
US09065V3024
End-of-day quote
Other stock markets
|
||
- USD | - |
|
02/07 | ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets | MT |
02/07 | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP | CI |
- Stock Market
- Equities
- ANIP Stock
- Stock
- News Biosante Pharmaceuticals Inc
- MarketScreener Editorial Features